Perfuze: €22 Million Raised And Clearance Received For Zipline Access Catheters
By Amit Chowdhry ● Mar 15, 2025
Perfuze, a leading medical device company dedicated to advancing stroke treatment, has received FDA 510(k) clearance for its Zipline Access Catheters. This milestone strengthens Perfuze’s growing portfolio of innovative neurovascular devices, enabling physicians to treat acute ischemic strokes rapidly, easily, and precisely. Plus, Perfuze has secured €22 million in follow-on funding in a round led by existing investors, including Earlybird, EQT Life Sciences, Seroba, and SV Health.